We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-17.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$47.7B
AUM Growth
-$12.1B
Cap. Flow
+$1.21B
Cap. Flow %
2.54%
Top 10 Hldgs %
20.23%
Holding
2,980
New
31
Increased
2,361
Reduced
322
Closed
49

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$22.7M
2
CNC icon
Centene
CNC
+$20M
3
IR icon
Ingersoll Rand
IR
+$18.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.8M
5
DLR icon
Digital Realty Trust
DLR
+$15.4M

Sector Composition

Rank Sector Weight
1 Technology 21.47%
2 Healthcare 14.79%
3 Financials 13.95%
4 Consumer Discretionary 9.78%
5 Communication Services 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KZR
2701
DELISTED
Kezar Life Sciences
KZR
$138K ﹤0.01%
3,155
+980
+45% +$39.9K
III icon
2702
Information Services Group
III
$251M
$137K ﹤0.01%
53,131
MLP icon
2703
Maui Land & Pineapple Co
MLP
$344M
$136K ﹤0.01%
12,480
BYSI icon
2704
BeyondSpring
BYSI
$35.8M
$135K ﹤0.01%
+10,565
New +$162K
NBN icon
2705
Northeast Bank
NBN
$1.14B
$135K ﹤0.01%
11,536
+250
+2% +$4.53K
FPRX
2706
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$135K ﹤0.01%
59,405
+1,972
+3% +$8.37K
CASI
2707
DELISTED
CASI Pharmaceuticals
CASI
$134K ﹤0.01%
6,556
OPTN
2708
DELISTED
OptiNose
OPTN
$134K ﹤0.01%
1,989
+53
+3% +$5.34K
SPRO icon
2709
Spero Therapeutics
SPRO
$73M
$133K ﹤0.01%
16,417
+1,030
+7% +$9.08K
ITI
2710
DELISTED
Iteris, Inc.
ITI
$133K ﹤0.01%
41,552
JNCE
2711
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$132K ﹤0.01%
27,735
+2,430
+10% +$14K
CELH icon
2712
Celsius Holdings
CELH
$7.03B
$131K ﹤0.01%
93,546
+3,375
+4% +$5.96K
TLPH icon
2713
Talphera
TLPH
$74.2M
$131K ﹤0.01%
5,548
PBPB
2714
DELISTED
Potbelly
PBPB
$130K ﹤0.01%
41,982
+7,200
+21% +$29.8K
SMHI icon
2715
SEACOR Marine Holdings
SMHI
$258M
$130K ﹤0.01%
29,788
UEC icon
2716
Uranium Energy
UEC
$5.57B
$130K ﹤0.01%
231,597
IPI icon
2717
Intrepid Potash
IPI
$469M
$129K ﹤0.01%
16,137
+820
+5% +$15.2K
RYZ
2718
Ryerson Holding Corp
RYZ
$1.46B
$129K ﹤0.01%
24,311
+213
+0.9% +$1.88K
ESCA icon
2719
Escalade
ESCA
$311M
$128K ﹤0.01%
21,535
+4,936
+30% +$40.5K
YARW
2720
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$128K ﹤0.01%
13
+7
+117% +$110K
NESR
2721
National Energy Services Reunited Corp
NESR
$2.93B
$128K ﹤0.01%
25,275
+947
+4% +$6.88K
GPX
2722
DELISTED
GP Strategies Corp.
GPX
$128K ﹤0.01%
19,606
ATEC icon
2723
Alphatec Holdings
ATEC
$1.44B
$127K ﹤0.01%
36,748
+100
+0.3% +$575
DHX icon
2724
DHI Group
DHX
$173M
$127K ﹤0.01%
58,648
-1,316
-2% -$3.53K
REI icon
2725
Ring Energy
REI
$339M
$127K ﹤0.01%
192,890
-23,464
-11% -$41.6K

Similar funds

RhumbLine Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, RhumbLine Advisers held 2,980 positions worth $47.7B, down 20% from $59.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 2.7%. RhumbLine Advisers opened 31 new positions and exited 49, leaving the 2,980-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2020 buy was PPD, Inc. Common Stock: 58,466 shares worth $1.04M.
  • RhumbLine Advisers added most to Prologis in Q1 2020, an estimated $22.7M increase.
  • RhumbLine Advisers's biggest Q1 2020 reduction was Apple, cutting an estimated $70.6M.
  • RhumbLine Advisers fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $34.9M.
  • RhumbLine Advisers's ten largest holdings make up 20% of its $47.7B portfolio in Q1 2020.
  • RhumbLine Advisers opened 31 new positions and closed 49 in Q1 2020.
  • RhumbLine Advisers's portfolio value fell 20% quarter-over-quarter to $47.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.